pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
glycine
Baylor College of Medicine
1 catalysts
Marketed
golodirsen
Vyondys 53 (golodirsen)
Duchenne Muscular Dystrophy
Dystrophin pre-mRNA
$SRPTSarepta Therapeutics, Inc.
1 catalysts
grape powder
Western New England University
1 catalysts
iKids-Growth
Children’s Hospital of Chongqing Medical University
1 catalysts
← prev
page 6 of 231
next →
131
Pain89
Neurology1
iNKT Cell Immunotherapy
Zhongshan Hospital
1 catalysts
influenza vaccine
Curtin University
1 catalysts
iruplinalkib
Qilu Pharmaceutical Co Ltd
1 catalysts
Marketed
isavuconazonium sulfate
Cresemba (isavuconazonium sulfate)
Aspergillosis
Astellas Pharma US Inc
1 catalysts
kava
Mayo Clinic
1 catalysts
Phase 3
lanifibranor
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Peroxisome proliferator-activated receptor
Inventiva SA
1 catalysts
lenvatinib
Cancer Institute and Hospital Chinese Academy of Medical Sciences
1 catalysts
Marketed
letermovir
Prevymis (letermovir)
Cytomegalovirus (HHV-5) Infections
Merck Sharp & Dohme Corp (Inactive)
1 catalysts
mazdutide
Innovent Biologics Inc
1 catalysts
mebikar
Pharmproject
1 catalysts
micronized progesterone
University of Utah
1 catalysts
Phase 2
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 catalysts
Marketed
norepinephrine
Norepinephrine (norepinephrine [INN])
Hypotension
Long Grove Pharmaceuticals LLC
1 catalysts
ofatumumab
Henan Provincial People's Hospital
1 catalysts
Marketed
olaparib
Lynparza (olaparib)
Epithelial Ovarian Cancer
AstraZeneca Pharmaceuticals LP
1 catalysts
oleocanthal
Aristotle University of Thessaloniki
1 catalysts
ozonated oil
Nigde Omer Halisdemir University
1 catalysts
pertuzumab + trastuzumab
Xijing Hospital
1 catalysts
pneumococcal (20-valent) vaccine
Beijing Minhai Biotechnology Co Ltd
1 catalysts
polyphenol-rich cocoa extract
German Sport University Cologne
1 catalysts
pucotenlimab
Lepu Biopharma Co Ltd
1 catalysts
Phase 3
raludotatug deruxtecan
Adenocarcinoma Of The Gastroesophageal Junction
Daiichi Sankyo Co Ltd
1 catalysts
recombinant type III humanized collagen
Chinese Academy of Medical Sciences Plastic Surgery Hospital
1 catalysts
risvutatug rezetecan
Changzhou Hengbang Pharmaceutical Co Ltd
1 catalysts
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 catalysts
Phase 3
serplulimab
Small-Cell Lung Cancer
Programmed cell death protein 1
Shanghai Henlius Biotech Inc
1 catalysts